Exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patients.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4463333)

Published in Diagn Interv Radiol on September 25, 2014

Authors

Gerald Hackl1, Thomas Gary, Klara Belaj, Franz Hafner, Peter Rief, Hannes Deutschmann, Marianne Brodmann

Author Affiliations

1: Division of Angiology, Department of Internal Medicine, Medical University Graz, Styria, Austria. gerald.hackl@medunigraz.at.

Articles cited by this

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg (2007) 14.17

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J (2011) 4.47

Percutaneous ultrasound guided thrombin injection: a new method for treating postcatheterization femoral pseudoaneurysms. J Vasc Surg (1998) 2.39

Treatment of iatrogenic false aneurysms. J Am Coll Surg (2003) 1.84

Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty. Am Heart J (2010) 1.83

Expanded indications for ultrasound-guided thrombin injection of pseudoaneurysms. J Vasc Surg (2000) 1.77

Efficacy and safety of the angioseal vascular closure device post antegrade puncture. Cardiovasc Intervent Radiol (2008) 1.61

Efficacy and safety of antegrade common femoral artery access closure using the Angio-Seal device: experience with 1889 interventions for critical limb ischemia in diabetic patients. J Endovasc Ther (2010) 1.54

Duplex scanning-guided thrombin injection for the treatment of iatrogenic pseudoaneurysms. J Vasc Surg (2002) 1.12

Retrospective evaluation of safety and effectiveness of the EXOSEAL vascular closure device for single vascular closure and closure after repeat puncture in diagnostic and interventional radiology: single-center experience. J Vasc Interv Radiol (2013) 0.88

Suitability of Exoseal vascular closure device for antegrade femoral artery puncture site closure. Cardiovasc Intervent Radiol (2012) 0.87

A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial). JACC Cardiovasc Interv (2009) 0.86

Angio-seal in antegrade endovascular interventions: technical success and complications in a 55-patient series. J Endovasc Ther (2007) 0.86

Efficacy and complications of Angioseal in antegrade puncture. Eur J Radiol (2005) 0.85

CIRSE vascular closure device registry. Cardiovasc Intervent Radiol (2010) 0.84

Obesity: an independent risk factor for insufficient hemostasis using the AngioSeal vascular closure device after antegrade puncture. Cardiovasc Intervent Radiol (2011) 0.84

Comparison of arterial closure devices in antegrade and retrograde punctures. J Endovasc Ther (2008) 0.81

Angioseal use after antegrade femoral arteriotomy in patients undergoing percutaneous revascularization for critical limb ischemia: a case series. Int J Cardiol (2006) 0.81

Comparison of enoxaparin and unfractionated heparin in endovascular interventions for the treatment of peripheral arterial occlusive disease: a randomized controlled trial. J Thromb Haemost (2011) 0.80

First-in-man experience with a new 7F vascular closure device (EXOSEAL™): the 7F ECLIPSE study. J Interv Cardiol (2012) 0.79

Safety and efficacy of periprocedural anticoagulation with enoxaparin in patients undergoing peripheral endovascular revascularization. Clin Appl Thromb Hemost (2013) 0.78

Arterial thrombosis after using Angio-Seal. Ann Vasc Surg (2011) 0.78

Evaluation of the 6-F ExoSeal vascular closure device in antegrade femoral artery punctures. J Endovasc Ther (2012) 0.78

Endovascular and interventional procedures in obese patients: a review of procedural technique modifications and radiation management. J Vasc Interv Radiol (2006) 0.78

Distal embolism of percutaneous arterial closure device resulting in critical limb ischemia. J Vasc Interv Radiol (2010) 0.77

Femoral artery occlusion with a percutaneous arterial closure device after a routine coronary angiogram: a case report and literature review. Ann R Coll Surg Engl (2011) 0.77

Vascular occlusion as a late complication of the Angio-Seal closure device. A review of literature. Minerva Cardioangiol (2007) 0.77

Articles by these authors

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. N Engl J Med (2015) 3.69

Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol (2004) 2.21

Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study. Ann Neurol (2015) 2.16

Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization. Chest (2010) 1.52

Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology (2002) 1.48

Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study. Ann Intern Med (2014) 1.42

Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study). J Endovasc Ther (2015) 1.38

Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J (2005) 1.23

Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med (2009) 1.21

Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One (2013) 1.15

Non-coronary atherosclerosis. Eur Heart J (2014) 1.11

Age dependency of successful recanalization in anterior circulation stroke: the ENDOSTROKE study. Cerebrovasc Dis (2013) 0.99

Secretoneurin, an angiogenic neuropeptide, induces postnatal vasculogenesis. Circulation (2004) 0.97

The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion. Am J Ophthalmol (2002) 0.94

Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients. PLoS One (2013) 0.93

The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis? Eur Radiol (2013) 0.92

Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure. Arthritis Rheum (2011) 0.92

Periprocedural aspects in mechanical recanalization for acute stroke: data from the ENDOSTROKE registry. Neuroradiology (2013) 0.87

Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2002) 0.86

Dissection of the internal carotid artery after SCUBA-diving: a case report and review of the literature. Neurologist (2011) 0.85

Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study). BMC Nephrol (2011) 0.83

Two polymorphisms in the fracalkine receptor CX3CR1 are not associated with peripheral arterial disease. Atherosclerosis (2003) 0.80

NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica. Ann Rheum Dis (2013) 0.80

99mTc-apcitide scintigraphy in patients with clinically suspected deep venous thrombosis and pulmonary embolism. Eur J Nucl Med Mol Imaging (2008) 0.79

Regulatory T cells improve nephrocalcinosis but not dystrophic cardiac calcinosis in DBA/2 mice. Am J Pathol (2013) 0.79

Axillary vein compression by Langer's axillary arch, an aberrant muscle bundle of the latissimus dorsi. Cardiovasc Pathol (2009) 0.79

Blood pressure measurements in patients with Takayasu arteritis: a work of caution. Ann Thorac Surg (2012) 0.79

Endoluminal therapy in patients with peripheral arterial disease: prospective assessment of quality of life in 190 patients. AJR Am J Roentgenol (2007) 0.79

Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients. Clin Chem Lab Med (2015) 0.78

Cerebrovascular complications and granuloma formation after wrapping or coating of intracranial aneurysms with cotton gauze and human fibrin adhesives: results from a single-center patient series over a 5-year period. J Neurosurg (2013) 0.78

High factor VIII activity, high plasminogen activator inhibitor 1 antigen levels and low factor XII activity contribute to a thrombophilic tendency in elderly venous thromboembolism patients. Acta Haematol (2010) 0.78

Cortical Superficial Siderosis and Risk of Bleeding after Thrombolysis for Ischemic Stroke. Cerebrovasc Dis (2015) 0.78

The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. Medicine (Baltimore) (2016) 0.77

The eternal tale of dialysis access vessels and restenosis: are drug-eluting balloons the solution? J Vasc Access (2014) 0.77

Graz Critical Limb Ischemia Score: A Risk Score for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease. Medicine (Baltimore) (2015) 0.75

Elevated Blood Urea Nitrogen is Associated With Critical Limb Ischemia in Peripheral Arterial Disease Patients. Medicine (Baltimore) (2015) 0.75

IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials (2014) 0.75

Renal failure caused by a partly calcified aortic aneurysm in a patient with dabigatran therapy: A case report. Medicine (Baltimore) (2017) 0.75

Gadobutrol in Renally Impaired Patients: Results of the GRIP Study. Invest Radiol (2017) 0.75

Endothelial function and carotid intima-media thickness in giant-cell arteritis. Eur J Clin Invest (2014) 0.75

Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial. Cardiovasc Intervent Radiol (2012) 0.75

Changes in lipid metabolism and extension of venous thromboembolism. Ann Nutr Metab (2014) 0.75

The influence of magnesium on the electrophysiological effects of erythromycin in the isolated Guinea pig heart. Cardiovasc Drugs Ther (2002) 0.75

[Periprocedual management of vitamin K antagonist's with low molecular weight heparins during invasive procedures--Consensus of experts]. Wien Klin Wochenschr (2013) 0.75

Progressive jugular vein thrombosis in cutaneous extramedullary plasmacytoma. Eur J Haematol (2014) 0.75

Massive pulmonary embolism caused by internal iliac vein thrombosis with free-floating thrombus formation in the inferior vena cava. Ann Vasc Surg (2012) 0.75

Lipoproteins and the development of restenosis after stent implantation in the superficial femoral artery in patients with peripheral artery disease. Cardiovasc Intervent Radiol (2010) 0.75

Lumbar artery aneurysms as a rare cause of life threatening retroperitoneal bleeding. Vasa (2013) 0.75

Novel Crossing System for the Recanalization of Complex Chronic Total Occlusions: Ex vivo Proof of Concept of the SoundBite Crossing System. J Invasive Cardiol (2017) 0.75

Thrombosis of the inferior vena cava related to Ormond's disease. Clin Rheumatol (2010) 0.75

Hyperlipidemia is associated with a higher pulmonary artery systolic pressure in patients after pulmonary embolism. Thromb Res (2011) 0.75

Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Endorsed by: the European Stroke Organisation (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J (2017) 0.75

Foreign body pulmonary embolism. Wien Klin Wochenschr (2013) 0.75

Fibromuscular dysplasia-related aneurysms: one-year follow-up after treatment with a flow-diverting stent. J Vasc Interv Radiol (2013) 0.75

Stent implantation in the superficial femoral artery: short thrombelastometry-derived coagulation times identify patients with late in-stent restenosis. Thromb Res (2012) 0.75

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J (2017) 0.75

Safety and Performance of Lithoplasty for Treatment of Calcified Peripheral Artery Lesions. J Am Coll Cardiol (2017) 0.75

A case of upper extremity deep vein thrombosis due to Kikuchi Fujimoto disease. Vasa (2012) 0.75

Venous thromboembolism in a patient with persistent inhibitor to coagulation factor V - a case report. Clin Chem Lab Med (2016) 0.75

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg (2017) 0.75

Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism. Obesity (Silver Spring) (2013) 0.75

UEMS training requirements for angiology and vascular medicine: european standards of postgraduate medical specialist training (ETR Document). Int Angiol (2016) 0.75

The value of FDG-PET in the diagnosis of thromboangiitis obliterans--a case series. Clin Rheumatol (2014) 0.75